Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Lung Cancer Marker Antibody (MOC-52), Novus Biologicals™
SDP

Catalog No. NBP24527702 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.02 mg
0.1 mg
0.2 mg
3 product options available for selection
Product selection table with 3 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP24527702 0.2 mg
NBP24527700 0.02 mg
NBP24527701 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 3 options available.
3 options
Catalog No. NBP24527702 Supplier Novus Biologicals Supplier No. NBP2452770.2MG

Item Discontinued This item has been discontinued by the supplier. Please to view product availability in your area.

Mouse Monoclonal Antibody

Ensure accurate, reproducible results in Immunocytochemistry, Immunofluorescence

Lung Cancer Marker MOC-52 Monoclonal antibody specifically detects Lung Cancer Marker MOC-52 in Human samples. It is validated for SDS-Page, Immunofluorescence, Immunocytochemistry.

Specifications

Antigen Lung Cancer Marker MOC-52
Applications SDS-Page, Immunofluorescence, Immunocytochemistry
Classification Monoclonal
Clone MOC-52
Concentration 0.2 mg/mL
Conjugate Unconjugated
Dilution SDS-Page, Immunofluorescence 0.5 - 1.0 ug/ml, Immunocytochemistry 0.5 - 1.0 ug/ml
Formulation 10mM PBS and 0.05% BSA with 0.05% Sodium Azide
Host Species Mouse
Immunogen Lung Cancer-associated antigen isolated from small cell lung carcinoma-derived cell line.
Molecular Weight of Antigen 145 kDa
Purification Method Protein A or G purified
Quantity 0.2 mg
Regulatory Status RUO
Research Discipline Cancer, Neuronal Cell Markers, Neuronal Stem Cell Markers, Stem Cell Markers
Primary or Secondary Primary
Gene ID (Entrez) 100133941
Test Specificity This MAb reacts with a membrane-associated protein present in normal and malignant neuroendocrine tissues including small cell lung cancer (SCLC). It stains neural and a variable number of endocrine tissues and in the lung it reacts preferentially with SCLC and carcinoids. Its epitope is destroyed during formalin fixation. This antibody was categorized during the First International Workshop on Small Cell Lung Cancer Antigens held in London in April 1987. There are two major types of Lung Carcinoma: non-small cell, which accounts for 80% of all cases; and small cell, which accounts for roughly 20% of all lung cancers reported. The lung continues to be a customary place for cancer migration from tumors elsewhere in the body. Treatment depends on the specific cell type of the cancer, level of progression and status of the individual patient.
Target Species Human
Content And Storage Store at 4C.
Form Purified
Isotype IgG1 κ
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.